This Black Friday, you can save 95% off of a 1-year membership to Brad Thomas’s Intelligent Income Investor.

This service is geared toward helping you collect the safest dividend income in the market.

It all starts with Brad’s “SWAN” portfolio, of the 10 best companies to own through any market.

Click here now to claim this 95% discount.

ARCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $724,000.00

Arcturus Therapeutics Insider Trading History Chart

Arcturus Therapeutics Share Price & Price History

^$16.48

▲ +0.05 (0.30%)

As of 11/25/2022 01:00 AM ET

Days: 30 | 90 | 365

See how to make money instead of spending it on Black Friday with this offer

From Legacy Research | Ad

Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.

Get Nomi’s latest stock market prediction for $19

Arcturus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/4/2022	Pad Chivukula	COO	Sell	8,100	$40.00	$324,000.00
12/16/2021	Pad Chivukula	COO	Sell	3,633	$40.00	$145,320.00
12/8/2021	Pad Chivukula	COO	Sell	6,367	$40.00	$254,680.00
11/1/2021	Pad Chivukula	COO	Sell	10,000	$44.41	$444,100.00
10/1/2021	Pad Chivukula	COO	Sell	10,000	$44.36	$443,600.00
9/1/2021	Pad Chivukula	COO	Sell	10,000	$55.86	$558,600.00
8/10/2021	Ultragenyx Pharmaceutical Inc.	Director	Sell	725,000	$55.44	$40,194,000.00	1,475,000
8/3/2021	Pad Chivukula	COO	Sell	10,000	$40.07	$400,700.00
1/4/2021	Pad Chivukula	COO	Sell	10,000	$46.40	$464,000.00
12/8/2020	Ultragenyx Pharmaceutical Inc.	Director	Sell	442,255	$105.54	$46,675,592.70	2,557,745
11/2/2020	Pad Chivukula	COO	Sell	10,000	$55.28	$552,800.00
10/1/2020	Pad Chivukula	COO	Sell	10,000	$42.83	$428,300.00
9/3/2020	Pad Chivukula	COO	Sell	10,000	$45.16	$451,600.00
6/12/2020	Keith C Kummerfeld	Insider	Buy	450	$33.33	$14,998.50	950
6/10/2020	Andy Sassine	CFO	Buy	5,000	$29.74	$148,700.00	273,245
6/10/2020	Joseph E. Payne	CEO	Buy	1,000	$31.69	$31,690.00
12/5/2019	Andy Sassine	CFO	Buy	5,649	$9.73	$54,964.77	268,245

THE BEST BLACK FRIDAY DEAL YET

From Legacy Research | Ad

Click here now to claim this 95% discount.

SEC Filings (Institutional Ownership Changes) for Arcturus Therapeutics (NASDAQ:ARCT)

83.55% of Arcturus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Arcturus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2022	Balyasny Asset Management LLC	339,383	$5.03M	0.0%	+3,039.8%	1.281%
11/16/2022	BNP Paribas Arbitrage SNC	60,353	$0.89M	0.0%	+1,096.8%	0.228%
11/15/2022	Alliancebernstein L.P.	22,800	$0.34M	0.0%	-12.6%	0.086%
11/15/2022	State Street Corp	2,730,462	$40.47M	0.0%	-2.7%	10.306%
11/15/2022	Vanguard Group Inc.	1,336,818	$19.81M	0.0%	+12.0%	5.046%
11/15/2022	Price T Rowe Associates Inc. MD	18,247	$0.27M	0.0%	+9.1%	0.069%
11/15/2022	Ensign Peak Advisors Inc	26,680	$0.40M	0.0%	-27.1%	0.101%
11/15/2022	Federated Hermes Inc.	3,567,497	$52.87M	0.2%	+0.2%	13.467%
11/15/2022	Formidable Asset Management LLC	15,650	$0.26M	0.1%	+4.7%	0.059%
11/15/2022	Bank of New York Mellon Corp	75,596	$1.12M	0.0%	+9.7%	0.285%
11/15/2022	Bayesian Capital Management LP	11,399	$0.17M	0.0%	N/A	0.043%
11/15/2022	BlackRock Inc.	1,960,589	$29.06M	0.0%	+3.0%	7.401%
11/15/2022	Commonwealth Equity Services LLC	10,140	$0.15M	0.0%	-5.5%	0.038%
11/14/2022	Point72 Asset Management L.P.	617,124	$9.15M	0.0%	-32.4%	2.329%
11/14/2022	Lazard Asset Management LLC	8,981	$0.13M	0.0%	N/A	0.034%
11/14/2022	Nuveen Asset Management LLC	110,088	$1.63M	0.0%	+1.4%	0.416%
11/14/2022	Integral Health Asset Management LLC	130,000	$1.93M	0.4%	-17.0%	0.491%
11/14/2022	E Fund Management Co. Ltd.	12,713	$0.19M	0.0%	-7.4%	0.048%
11/14/2022	Hennion & Walsh Asset Management Inc.	60,363	$0.90M	0.1%	-2.3%	0.228%
11/10/2022	Credit Suisse AG	33,087	$0.49M	0.0%	+33.5%	0.124%
11/10/2022	ExodusPoint Capital Management LP	47,552	$0.71M	0.0%	N/A	0.179%
11/10/2022	Dimensional Fund Advisors LP	143,118	$2.12M	0.0%	-4.2%	0.538%
11/10/2022	Tower Research Capital LLC TRC	3,727	$55K	0.0%	-47.7%	0.014%
11/10/2022	UBS Group AG	3,480	$52K	0.0%	-90.6%	0.013%
11/4/2022	Vontobel Holding Ltd.	72,852	$1.08M	0.0%	-5.2%	0.274%
11/4/2022	Bank Julius Baer & Co. Ltd Zurich	59,617	$0.88M	0.0%	-52.2%	0.224%
11/3/2022	ACT Capital Management LLC	120,400	$1.78M	2.5%	-46.9%	0.453%
11/3/2022	Barclays PLC	120,743	$1.79M	0.0%	+170.5%	0.454%
11/2/2022	Daiwa Securities Group Inc.	4,860	$72K	0.0%	-17.7%	0.018%
11/1/2022	Great West Life Assurance Co. Can	1,816	$27K	0.0%	N/A	0.007%
10/21/2022	Sumitomo Mitsui Trust Holdings Inc.	1,459,415	$21.63M	0.0%	+1.6%	5.491%
10/17/2022	ARK Investment Management LLC	2,181,703	$32.33M	0.2%	-5.3%	8.209%
10/14/2022	Green Alpha Advisors LLC	23,362	$0.35M	0.3%	-69.4%	0.088%
9/16/2022	Federated Hermes Inc.	3,561,097	$56.05M	0.2%	-5.3%	13.400%
8/24/2022	Prelude Capital Management LLC	11,753	$0.19M	0.0%	N/A	0.044%
8/22/2022	Legal & General Group Plc	13,871	$0.22M	0.0%	+10.4%	0.052%
8/19/2022	Walleye Capital LLC	67,978	$1.07M	0.0%	N/A	0.256%
8/16/2022	Formidable Asset Management LLC	14,950	$0.24M	0.1%	+6.4%	0.056%
8/15/2022	State Street Corp	2,806,918	$44.18M	0.0%	-12.8%	10.562%
8/15/2022	PDT Partners LLC	74,636	$1.18M	0.1%	+50.8%	0.281%
8/15/2022	Point72 Hong Kong Ltd	6,493	$0.10M	0.0%	+3,653.2%	0.024%
8/15/2022	Cubist Systematic Strategies LLC	39,749	$0.63M	0.0%	+659.3%	0.150%
8/15/2022	Point72 Asset Management L.P.	913,323	$14.38M	0.1%	+114.8%	3.437%
8/15/2022	Millennium Management LLC	204,596	$3.22M	0.0%	N/A	0.770%
8/13/2022	Wells Fargo & Company MN	176,149	$2.77M	0.0%	+12.5%	0.667%
8/12/2022	Northern Trust Corp	208,896	$3.29M	0.0%	+7.8%	0.791%
8/12/2022	Virtus ETF Advisers LLC	8,039	$0.13M	0.0%	+77.4%	0.030%
8/12/2022	Ensign Peak Advisors Inc	36,620	$0.58M	0.0%	+420.2%	0.139%
8/12/2022	Credit Suisse AG	24,778	$0.39M	0.0%	-3.4%	0.093%
8/12/2022	Rafferty Asset Management LLC	200,186	$3.15M	0.0%	-33.8%	0.753%
8/12/2022	BNP Paribas Arbitrage SA	5,043	$79K	0.0%	+63.4%	0.019%
8/12/2022	Rhumbline Advisers	25,698	$0.40M	0.0%	-4.6%	0.097%
8/11/2022	UBS Group AG	36,846	$0.58M	0.0%	-81.8%	0.139%
8/11/2022	Alps Advisors Inc.	15,677	$0.25M	0.0%	-42.2%	0.059%
8/9/2022	Swiss National Bank	55,900	$0.88M	0.0%	+12.0%	0.212%
8/9/2022	Pictet Asset Management SA	70,374	$1.11M	0.0%	+41.2%	0.266%
8/8/2022	Walleye Capital LLC	67,978	$1.07M	0.0%	N/A	0.257%
8/5/2022	State Board of Administration of Florida Retirement System	16,711	$0.26M	0.0%	+71.0%	0.063%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	19,276	$0.30M	0.0%	-64.7%	0.073%
8/5/2022	Los Angeles Capital Management LLC	12,322	$0.19M	0.0%	-79.3%	0.047%
8/4/2022	Nikko Asset Management Americas Inc.	1,436,194	$17.95M	0.2%	+2.4%	5.436%
8/4/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	13,915	$0.22M	0.0%	+67.7%	0.053%
8/3/2022	Integral Health Asset Management LLC	156,553	$2.46M	0.5%	+25.2%	0.593%
7/29/2022	SG Americas Securities LLC	22,678	$0.36M	0.0%	N/A	0.086%
7/27/2022	Vontobel Holding Ltd.	76,810	$1.21M	0.0%	+99.5%	0.291%
7/26/2022	Sumitomo Mitsui Trust Holdings Inc.	1,436,194	$22.61M	0.0%	+2.4%	5.436%
7/22/2022	Bank Julius Baer & Co. Ltd Zurich	124,838	$1.97M	0.0%	-42.5%	0.473%
7/19/2022	Hennion & Walsh Asset Management Inc.	61,761	$0.97M	0.1%	+4.0%	0.234%
7/11/2022	ARK Investment Management LLC	2,303,751	$45.80M	0.3%	-3.4%	8.720%
7/8/2022	Green Alpha Advisors LLC	76,250	$1.20M	0.3%	+231.3%	0.289%
6/30/2022	Amalgamated Bank	2,542	$69K	0.0%	N/A	0.010%
6/7/2022	Bank of America Corp DE	56,972	$1.54M	0.0%	-55.4%	0.216%
5/18/2022	BNP Paribas Arbitrage SA	3,087	$83K	0.0%	-73.4%	0.012%
5/17/2022	Advisors Asset Management Inc.	5,563	$0.15M	0.0%	-48.8%	0.021%
5/17/2022	Royal Bank of Canada	6,036	$0.16M	0.0%	-39.6%	0.023%
5/16/2022	California State Teachers Retirement System	27,391	$0.74M	0.0%	-6.2%	0.104%
5/16/2022	Goldman Sachs Group Inc.	281,990	$7.60M	0.0%	+3.2%	1.067%
5/16/2022	PDT Partners LLC	49,500	$1.34M	0.1%	-6.6%	0.187%
5/16/2022	Wellington Management Group LLP	56,273	$1.52M	0.0%	+10.8%	0.213%
5/16/2022	State Street Corp	3,217,957	$86.76M	0.0%	+56.5%	12.180%
5/16/2022	Invesco Ltd.	21,740	$0.59M	0.0%	+163.0%	0.082%
5/16/2022	UBS Group AG	202,235	$5.45M	0.0%	+104.2%	0.765%
5/16/2022	Granahan Investment Management LLC	64,851	$1.75M	0.0%	+17.0%	0.245%
5/13/2022	Bellevue Group AG	40,900	$1.10M	0.0%	-1.7%	0.155%
5/13/2022	Northern Trust Corp	193,709	$5.22M	0.0%	-4.2%	0.733%
5/13/2022	Charles Schwab Investment Management Inc.	154,551	$4.17M	0.0%	+2.5%	0.585%
5/13/2022	Federated Hermes Inc.	3,761,900	$101.42M	0.2%	+1.8%	14.239%
5/13/2022	American International Group Inc.	10,481	$0.28M	0.0%	-6.6%	0.040%
5/13/2022	Vanguard Group Inc.	1,153,513	$31.10M	0.0%	+0.5%	4.366%
5/13/2022	Vontobel Holding Ltd.	38,503	$1.04M	0.0%	-3.8%	0.146%
5/13/2022	Dimensional Fund Advisors LP	217,572	$5.87M	0.0%	+190.3%	0.824%
5/12/2022	Integral Health Asset Management LLC	125,000	$3.37M	0.9%	+92.3%	0.473%
5/12/2022	Shelton Capital Management	53,000	$1.43M	0.1%	+10.4%	0.201%
5/12/2022	BlackRock Inc.	1,695,639	$45.72M	0.0%	-3.6%	6.418%
5/12/2022	Rhumbline Advisers	26,927	$0.73M	0.0%	-8.2%	0.102%
5/12/2022	Metropolitan Life Insurance Co NY	1,394	$38K	0.0%	-77.9%	0.005%
5/12/2022	Jacob Asset Management of New York LLC	24,915	$0.67M	0.4%	-17.8%	0.094%
5/12/2022	MetLife Investment Management LLC	12,327	$0.33M	0.0%	+66.3%	0.047%
5/12/2022	Capital Fund Management S.A.	34,926	$0.94M	0.0%	N/A	0.132%
5/12/2022	E Fund Management Co. Ltd.	11,910	$0.32M	0.0%	N/A	0.045%

Data available starting January 2016

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.

Today's Range

Now: $16.48

$16.06

$16.60

50 Day Range

MA: $16.67

$13.05

$23.38

52 Week Range

Now: $16.48

$11.70

$48.75

Volume

108,445 shs

Average Volume

815,494 shs

Market Capitalization

$436.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.51

Who are the company insiders with the largest holdings of Arcturus Therapeutics?: Arcturus Therapeutics' top insider shareholders include:
Ultragenyx Pharmaceutical Inc (Director)
Pad Chivukula (COO)
Learn More about top insider investors at Arcturus Therapeutics.
Who are the major institutional investors of Arcturus Therapeutics?: Arcturus Therapeutics' top institutional investors include:
Federated Hermes Inc. — 13.47%
State Street Corp — 10.31%
ARK Investment Management LLC — 8.21%
BlackRock Inc. — 7.40%
Sumitomo Mitsui Trust Holdings Inc. — 5.49%
Vanguard Group Inc. — 5.05%
Learn More about top institutional investors of Arcturus Therapeutics stock.
Which major investors are selling Arcturus Therapeutics stock?: Within the last quarter, ARCT stock was sold by these institutional investors:
Point72 Asset Management L.P.
ARK Investment Management LLC
ACT Capital Management LLC
State Street Corp
Bank Julius Baer & Co. Ltd Zurich
Boothbay Fund Management LLC
Green Alpha Advisors LLC
UBS Group AG
Which major investors are buying Arcturus Therapeutics stock?: In the last quarter, ARCT stock was purchased by institutional investors including:
Balyasny Asset Management LLC
Vanguard Group Inc.
Barclays PLC
BlackRock Inc.
BNP Paribas Arbitrage SNC
ExodusPoint Capital Management LP
Sumitomo Mitsui Trust Holdings Inc.
Jane Street Group LLC

THE BEST BLACK FRIDAY DEAL YET

From Legacy Research | Ad

Click here now to claim this 95% discount.

ARCT Insider Trading

Arcturus Therapeutics Insider Trading History Chart

Arcturus Therapeutics Share Price & Price History

Arcturus Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Arcturus Therapeutics (NASDAQ:ARCT)

Institutional Buying and Selling by Quarter

Arcturus Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Arcturus Therapeutics?

Who are the major institutional investors of Arcturus Therapeutics?

Which major investors are selling Arcturus Therapeutics stock?

Which major investors are buying Arcturus Therapeutics stock?